Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma
Crossref DOI link: https://doi.org/10.1186/1479-5876-13-S1-O3
Published Online: 2015-01-15
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Daud, Adil
Takamura, Kathryn Toshimi
Diep, Tu
Heller, Richard
Pierce, Robert H.
Article History
First Online: 15 January 2015